Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to the study details are visible.
    Difference
    0.1%
    Check dated 2025-12-01T18:53:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.1; Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T15:09:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. This change does not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:43:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study record now shows updated results posting dates and last update timestamps.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Results Posted section with Overall Survival and Oral Cancer-free Survival, including time frames and Kaplan-Meier analysis, and a link to the Study Protocol and SAP PDF. Removed Exploratory Objectives on oral microbiome, neo-antigens, and immune infiltrates from the study plan.
    Difference
    2%
    Check dated 2025-10-26T20:47:53.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    4%
    Check dated 2025-10-05T10:13:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.